These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 7962683)

  • 1. Attenuation of the prolactin-stimulating and hyperthermic effects of nefazodone after subacute treatment.
    Walsh AE; Cowen PJ
    J Clin Psychopharmacol; 1994 Aug; 14(4):268-73. PubMed ID: 7962683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonlinear pharmacokinetics of nefazodone after escalating single and multiple oral doses.
    Kaul S; Shukla UA; Barbhaiya RH
    J Clin Pharmacol; 1995 Aug; 35(8):830-9. PubMed ID: 8522641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacology and neurochemistry of nefazodone, a novel antidepressant drug.
    Taylor DP; Carter RB; Eison AS; Mullins UL; Smith HL; Torrente JR; Wright RN; Yocca FD
    J Clin Psychiatry; 1995; 56 Suppl 6():3-11. PubMed ID: 7649970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single- and multiple-dose pharmacokinetics of nefazodone in patients with hepatic cirrhosis.
    Barbhaiya RH; Shukla UA; Natarajan CS; Behr DA; Greene DS; Sainati SM
    Clin Pharmacol Ther; 1995 Oct; 58(4):390-8. PubMed ID: 7586930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroendocrine and temperature effects of nefazodone in healthy volunteers.
    Walsh AE; Hockney RA; Campling G; Cowen PJ
    Biol Psychiatry; 1993 Jan; 33(2):115-9. PubMed ID: 8382534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the metabolites of the antidepressant drug nefazodone in human urine and plasma.
    Mayol RF; Cole CA; Luke GM; Colson KL; Kerns EH
    Drug Metab Dispos; 1994; 22(2):304-11. PubMed ID: 8013286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nefazodone: preclinical pharmacology of a new antidepressant.
    Eison AS; Eison MS; Torrente JR; Wright RN; Yocca FD
    Psychopharmacol Bull; 1990; 26(3):311-5. PubMed ID: 2274630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coadministration of nefazodone and benzodiazepines: II. A pharmacokinetic interaction study with triazolam.
    Barbhaiya RH; Shukla UA; Kroboth PD; Greene DS
    J Clin Psychopharmacol; 1995 Oct; 15(5):320-6. PubMed ID: 8830062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the steady-state pharmacokinetics of nefazodone after administration of 200 mg twice daily or 400 mg once daily in the morning or evening.
    Marathe PH; Lee JS; Greene DS; Barbhaiya RH
    Br J Clin Pharmacol; 1996 Jan; 41(1):21-7. PubMed ID: 8824689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics, absolute bioavailability, and disposition of [14C]nefazodone in the dog.
    Shukla UA; Marathe PH; Pittman KA; Barbhaiya RH
    Drug Metab Dispos; 1993; 21(3):502-7. PubMed ID: 8100508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coadministration of nefazodone and benzodiazepines: III. A pharmacokinetic interaction study with alprazolam.
    Greene DS; Salazar DE; Dockens RC; Kroboth P; Barbhaiya RH
    J Clin Psychopharmacol; 1995 Dec; 15(6):399-408. PubMed ID: 8748428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety, tolerance, and preliminary pharmacokinetics of nefazodone after administration of single and multiple oral doses to healthy adult male volunteers: a double-blind, phase I study.
    Barbhaiya RH; Marathe PH; Greene DS; Mayol RF; Shukla UA; Gammans RR; Pittman KA; Robinson D
    J Clin Pharmacol; 1995 Oct; 35(10):974-84. PubMed ID: 8568015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers.
    Bergman AJ; Stevens C; Zhou Y; Yi B; Laethem M; De Smet M; Snyder K; Hilliard D; Tanaka W; Zeng W; Tanen M; Wang AQ; Chen L; Winchell G; Davies MJ; Ramael S; Wagner JA; Herman GA
    Clin Ther; 2006 Jan; 28(1):55-72. PubMed ID: 16490580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of interaction between nefazodone and cimetidine: a steady state pharmacokinetic study in humans.
    Barbhaiya RH; Shukla UA; Greene DS
    Br J Clin Pharmacol; 1995 Aug; 40(2):161-5. PubMed ID: 8562300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of pharmacokinetic and pharmacodynamic drug interactions between nefazodone and digoxin in healthy male volunteers.
    Dockens RC; Greene DS; Barbhaiya RH
    J Clin Pharmacol; 1996 Feb; 36(2):160-7. PubMed ID: 8852392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic dose range of nefazodone in the treatment of major depression.
    Robinson DS; Marcus RN; Archibald DG; Hardy SA
    J Clin Psychiatry; 1996; 57 Suppl 2():6-9. PubMed ID: 8626365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of amitriptyline, nefazodone and paroxetine on performance and brain indices of visual selective attention and working memory.
    van Laar MW; Volkerts ER; Verbaten MN; Trooster S; van Megen HJ; Kenemans JL
    Psychopharmacology (Berl); 2002 Aug; 162(4):351-63. PubMed ID: 12172688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of repeated treatment with oxaprotiline enantiomers on central 5-HT receptor subpopulations.
    Dereń-Wesołek A; Maj J
    Pol J Pharmacol; 1993; 45(2):133-50. PubMed ID: 8401766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of pharmacokinetic and pharmacodynamic interactions after coadministration of nefazodone and haloperidol.
    Barbhaiya RH; Shukla UA; Greene DS; Breul HP; Midha KK
    J Clin Psychopharmacol; 1996 Feb; 16(1):26-34. PubMed ID: 8834415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loratadine and terfenadine interaction with nefazodone: Both antihistamines are associated with QTc prolongation.
    Abernethy DR; Barbey JT; Franc J; Brown KS; Feirrera I; Ford N; Salazar DE
    Clin Pharmacol Ther; 2001 Mar; 69(3):96-103. PubMed ID: 11240972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.